BacteriaFAQ.com

When we think of antibiotic resistance, MRSA often steals the spotlight. But lurking in its shadow is another, equally concerning threat: Vancomycin-Intermediate Staphylococcus aureus, or VISA. This superbug has developed a partial resistance to vancomycin, an antibiotic often considered the last line of defense against serious staph infections. Understanding VISA is critical for anyone managing hygiene in high-risk environments, as its presence signals a significant challenge in infection control.

Definition and Overview of VISA

VISA is a specific strain of Staphylococcus aureus that is not easily killed by standard doses of the powerful antibiotic vancomycin. It isn't fully resistant (that would be VRSA), but its "intermediate" resistance means that treatments that should work become less effective, allowing infections to persist and worsen.

Staphylococcus aureus is a Gram-positive bacterium, commonly found on the skin and in the noses of healthy people. While often harmless, it can cause serious infections if it enters the bloodstream or internal tissues. VISA strains typically emerge in patients undergoing long-term vancomycin therapy, as the bacteria adapt and evolve to survive the drug's effects. The key trait of VISA is its thickened cell wall, which acts like a shield, trapping vancomycin molecules before they can reach their target and kill the bacterium.

Where It’s Commonly Found

VISA is almost exclusively a healthcare-associated pathogen. Its emergence is closely linked to environments where vancomycin is frequently used to treat other serious infections, particularly MRSA.

• Hospitals and Long-Term Care Facilities: These are the primary reservoirs for VISA. Patients with chronic wounds, indwelling medical devices like catheters or IV lines, or weakened immune systems are most at risk.
• Intensive Care Units (ICUs): The high concentration of critically ill patients receiving extensive antibiotic treatments makes ICUs a hotspot for the development and spread of resistant bacteria.
• Dialysis Centers: Patients undergoing regular dialysis have frequent and prolonged contact with the healthcare system, increasing their exposure risk.

The bacteria can contaminate high-touch surfaces such as bed rails, medical equipment, doorknobs, and over-bed tables. It can then be transferred via the hands of healthcare workers to other patients.

Health Risks Associated with VISA

Infections caused by VISA are difficult to treat and can be life-threatening. Because vancomycin is less effective, physicians must turn to alternative antibiotics that may be more toxic or less proven. The delay in finding an effective treatment can allow the infection to become more severe.

Common VISA infections include:

• Bacteremia (Bloodstream Infections): Can lead to sepsis, a life-threatening response to infection.
• Endocarditis: A dangerous infection of the heart valves.
• Pneumonia: Particularly in ventilated patients.
• Osteomyelitis: A severe bone infection.
• Complex Skin and Wound Infections: Especially in surgical sites or chronic ulcers.

Transmission occurs primarily through direct contact with a contaminated surface or an infected person. Without strict hygiene protocols, VISA can spread rapidly within a healthcare facility.

How to Kill and Control VISA

Controlling VISA requires a multi-pronged approach focused on stringent cleaning, disinfection, and antibiotic stewardship. Since it's a hardy bacterium, simply wiping a surface isn't enough.

• Effective Disinfection: Use an EPA-registered, hospital-grade disinfectant proven effective against Staphylococcus aureus (including resistant strains). Disinfectant wipes are particularly useful for ensuring consistent application and correct concentration.
• Mind the Dwell Time: Dwell time is the period a disinfectant must remain wet on a surface to kill the pathogen. For Staphylococcus aureus, this can range from 30 seconds to 10 minutes, depending on the product. Always check the product label and ensure the surface stays visibly wet for the entire required duration. Wiping it dry too soon will not achieve proper disinfection.
• Focus on High-Touch Surfaces: Regularly disinfect all high-touch points, including medical devices, call buttons, keyboards, and furniture in patient rooms and common areas.
• Hand Hygiene: This is the single most important measure. Strict adherence to handwashing with soap and water or using an alcohol-based hand sanitizer is essential for all staff, patients, and visitors.

Who Should Be Concerned

While VISA is primarily a concern in healthcare, the responsibility for controlling it extends to several key groups:

• Infection Control Practitioners and Hospital Administrators: They are responsible for implementing, enforcing, and monitoring hygiene protocols, staff training, and antibiotic stewardship programs.
• Janitorial and Environmental Services (EVS) Staff: As the frontline defense in environmental cleaning, EVS teams must be thoroughly trained on proper disinfection techniques, including using the right products and adhering to specified dwell times.
• Nurses and Healthcare Providers: They must practice impeccable hand hygiene and ensure that all medical equipment is properly sanitized between patients to prevent cross-contamination.

Ultimately, preventing the spread of VISA is crucial for protecting vulnerable patients. A robust environmental cleaning and disinfection program is not just about cleanliness—it's a critical component of patient safety.

For facilities looking to ensure their cleaning protocols are effective against tough pathogens like VISA, we recommend using EPA-registered disinfectant products. Wipes.com offers a range of professional-grade disinfecting wipes designed for healthcare environments that are proven to kill Staphylococcus aureus and other dangerous bacteria, helping you maintain a safer and more hygienic facility.